| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.051 | 0.3 |